0 NASDAQ Companies - February 5, 2024Treasure Global CEO Demonstrates Confidence in Company’s Future Through Share PurchaseNEW YORK and KUALA LUMPUR, Malaysia, Feb. 05, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“TGL” or the […]Read More
0 NASDAQ Companies - February 5, 2024Foresight Successfully Completes Project with Prominent Japanese Vehicle ManufacturerPaving the Way for Future Collaborations: Exploring Next Steps in Integrating Foresight’s Advanced Automatic Camera Calibration Solution Ness Ziona, Israel, […]Read More
0 NASDAQ Companies - February 5, 2024LiveOne (NASDAQ: LVO) Subsidiary Splitmind Wins Grammy– Splitmind’s Steven Shaeffer and Simbo Produced Grammy Award-Winning Album Church Clothes 4 by Lecrae – Splitmind Music Collective has […]Read More
0 NASDAQ Companies - February 5, 2024Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024CAMBRIDGE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine […]Read More
0 NASDAQ Companies - February 5, 2024eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceSOLANA BEACH, Calif. and REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader […]Read More
0 NASDAQ Companies - February 5, 2024Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceBOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing […]Read More
0 NASDAQ Companies - February 5, 2024Maris-Tech Receives Order for Approximately $190,000 From a Return Customer in the Defense IndustryFor a miniature low-power solution to enhance gun sight capabilities in tactical applications Rehovot, Israel, Feb. 05, 2024 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - February 5, 2024Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024HAMPTON, N.J., Feb. 05, 2024 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing 12 week […]Read More
0 NASDAQ Companies - February 5, 2024Mesa Labs Announces Third Quarter ResultsLAKEWOOD, Colo., Feb. 05, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture […]Read More
0 NASDAQ Companies - February 5, 2024Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual MeetingREDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on […]Read More